Fitbit Third Quarter Growth Differs from Analysts’ Estimates
Similar Posts
Orchestra BioMed Announces Clinical Data Demonstrating a Significant and Sustained Reduction in Blood Pressure in MODERATO II Control Patients After Crossover to BackBeat Cardiac Neuromodulation Therapy
Data Shows BackBeat CNT Reduces Blood Pressure in Crossover Hypertensive Patients Orchestra BioMed, Inc., (“Orchestra BioMed” or the “Company”),…
Microsoft Accelerates Industry Cloud Strategy for Healthcare with the Acquisition of Nuance
Acquisition will combine solutions and expertise to deliver new cloud and AI capabilities across healthcare and other industries Microsoft…
Bone Health Technologies Receives Patent for OsteoBoost Vibration Belt
This patent covers the OsteoBoost tracking and reporting features, as well as for a wearable apparatus for treating or…
